Skip to content

Simplexa™ C. difficile Universal Direct MOL2975

by DiaSorin Molecular LLC

Ref MOL2975

Simplexa C. difficile Universal Direct MOL2975 is a clostridium difficile nucleic acid IVD (EU IVDD general IVD; FDA Class I; FDA product code OMN, C. Difficile Nucleic Acid Amplification Test Assay) made by DiaSorin Molecular LLC, registered in EUDAMED on 9 Oct 2026 (Basic UDI-DI B-20816101025583), cleared under FDA 510(k) K113433 on 4 Apr 2012 and listed in FDA GUDID since 22 Sep 2016 (UDI-DI 20816101025583), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K113433

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-20816101025583 Basic UDI-DI 20816101025583UDI-DIDate9 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number20816101025583 UDI-DI Date22 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK113433 Date4 Apr 2012DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-20816101025583 registered 9 Oct 2026 Active
  • FDA 510(k) K113433 decided 4 Apr 2012 Active
  • FDA GUDID UDI-DI 20816101025583 listed 22 Sep 2016 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K113433
  2. Listed FDA GUDID 20816101025583
  3. Registered EUDAMED B-20816101025583

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Simplexa™ C. difficile Universal Direct
Generic name
Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
MOL2975
Primary DI / UDI-DI
20816101025583
Basic UDI-DI
B-20816101025583
510(k) Number
FDA product code
OMN
EMDN code
W0105011804 C.difficile by na reagents
GMDN term
Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
866.2660
EU registration type
Legacy device (under a directive)
EU market of registration
Italy
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CLOSTRIDIUM DIFFICILE.

Other devices from DiaSorin Molecular LLC

See all devices from DiaSorin Molecular LLC →

Properties

  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (16, all answered No)